Despite compliance with lifestyle recommendations, some children and adolescents with
high-risk hyperlipidemia will require lipid-lowering drug therapy, particularly those with …

Regenerative medicine is becoming a rapidly evolving technique in today's biomedical
progress scenario. Scientists around the world suggest the use of naturally synthesized …

Objective The development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology …

METHODS This CPG was developed in accordance with the AACE Protocol for
Standardized Production of Clinical Practice Guidelines—2010 Update (

Objective To quantify the unintended effects of statins according to type, dose, and duration
of use. Design Prospective open cohort study using routinely collected data. Setting 368 …

Background The role of lipid-lowering treatments in renoprotection for patients with diabetes
is debated. We studied the renal effects of two statins in patients with diabetes who had …

Patients at risk of coronary heart disease may not achieve recommended low-density
lipoprotein (LDL) cholesterol goals on statin monotherapy. This study was designed to …

Atorvastatin has been shown to reduce coronary events and revascularization procedures in
patients with multiple risk factors for coronary heart disease. Recent studies with atorvastatin …

HMG-CoA reductase inhibitors (statins) are the mainstay in the pharmacologic management
of dyslipidemia. Since they are widely prescribed, their safety remains an issue of concern …

Aims The efficacy and safety of rosuvastatin, atorvastatin, and placebo were compared in
patients with the metabolic syndrome. Methods and results Patients with the metabolic …